13.00

Registration

13.30

Introduction

13.35

Alleyn Plowright, Sanofi
Joining forces: applications of Chemical Biology and Medicinal Chemistry to discover novel biological tools and utilise new therapeutic modalities

14.20

Miles Congreve, Heptares Therapeutics Ltd.
Structure-Based Discovery of Small Molecule and Peptide Agents for GPCR Targets

15.05

Coffee Break

15.30

Gisbert Schneider, ETH Zurich  
Artificially-intelligent drug design

16.15

Jozef Vanden Broeck, University of Leuwen
Advances in understanding the mechanisms of RNA interference in insects

17.00

David Spring, University of Cambridge
Enriching Chemical Space to Drug Undruggable Targets

17.45

Aperitif